| Jordan Wroblewski, | |
|
1521 Gull Rd, Kalamazoo, MI 49048-1640 | |
| (269) 226-6000 | |
| Not Available |
| Full Name | Jordan Wroblewski |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 1521 Gull Rd, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144648551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5101021228 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Michigan University School Of Medicine | 7517113954 | 67 |
News Archive
Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
The National Institutes of Health (NIH) is seeking public input on a proposed new policy designed to facilitate the research community's access to data resulting from NIH-funded, genome-wide association studies.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
Over the past two months, China has grappled with thousands of coronavirus deaths and infections. Through January and early February, the country reported thousands of new infections each day. Though the number of new infections has declined steadily, that is not the case outside China
› Verified 2 days ago
| Entity Name | Ascension Medical Group Promed |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497709869 PECOS PAC ID: 7315856077 Enrollment ID: O20031216000478 |
News Archive
Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
The National Institutes of Health (NIH) is seeking public input on a proposed new policy designed to facilitate the research community's access to data resulting from NIH-funded, genome-wide association studies.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
Over the past two months, China has grappled with thousands of coronavirus deaths and infections. Through January and early February, the country reported thousands of new infections each day. Though the number of new infections has declined steadily, that is not the case outside China
› Verified 2 days ago
| Entity Name | Family Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811065576 PECOS PAC ID: 1759370216 Enrollment ID: O20040510000899 |
News Archive
Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
The National Institutes of Health (NIH) is seeking public input on a proposed new policy designed to facilitate the research community's access to data resulting from NIH-funded, genome-wide association studies.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
Over the past two months, China has grappled with thousands of coronavirus deaths and infections. Through January and early February, the country reported thousands of new infections each day. Though the number of new infections has declined steadily, that is not the case outside China
› Verified 2 days ago
| Entity Name | Western Michigan University School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316212343 PECOS PAC ID: 7517113954 Enrollment ID: O20120817000243 |
News Archive
Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
The National Institutes of Health (NIH) is seeking public input on a proposed new policy designed to facilitate the research community's access to data resulting from NIH-funded, genome-wide association studies.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
Over the past two months, China has grappled with thousands of coronavirus deaths and infections. Through January and early February, the country reported thousands of new infections each day. Though the number of new infections has declined steadily, that is not the case outside China
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Wroblewski, 1521 Gull Rd, Kalamazoo, MI 49048-1640 Ph: () - | Jordan Wroblewski, 1521 Gull Rd, Kalamazoo, MI 49048-1640 Ph: (269) 226-6000 |
News Archive
Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
The National Institutes of Health (NIH) is seeking public input on a proposed new policy designed to facilitate the research community's access to data resulting from NIH-funded, genome-wide association studies.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
Over the past two months, China has grappled with thousands of coronavirus deaths and infections. Through January and early February, the country reported thousands of new infections each day. Though the number of new infections has declined steadily, that is not the case outside China
› Verified 2 days ago
Dr. Amanda Keating Walker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Paul I Berkowitz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John Street, Box 42, Kalamazoo, MI 49007 Phone: 269-341-6417 Fax: 269-341-8743 | |
Malcolm Hamilton, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Dr. Benjamin Baines Mize, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 N Park St, Kalamazoo, MI 49007 Phone: 269-382-2500 Fax: 269-384-8617 | |
Dr. Wendy L Bauer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2854 S 11th St, Kalamazoo, MI 49009 Phone: 269-345-6197 Fax: 269-345-9734 | |
Brandi L Boone, CNM Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 |